Toyos Clinic submits Latest Dry Eye Research - Red Light Therapy

Toyos Clinic has been leading the way in Dry Eye Research since 1999.  Both Rolando Toyos, MD and Melissa Toyos, MD have presented at least one study at a major meeting since the year 2000.  Dr. R. Toyos won the American Society of Cataract and Refractive Surgery research award and was chosen to give the prestigious Stein Lecture.  Dr. M. Toyos won the Lieberman Research Award.  They currently have 6 active research studies in dry eye, wavelight lasik, cataract, and glaucoma.  Dr. Rolando Toyos will be presenting his completed project in Red Light Therapy for dry eye.

The Effects of Red Light Technology on Dry Eye due to Meibomian Gland Dysfunction
Purpose: To present data on the effectiveness of a red light technology (RLT) in treating Evaporative Dry Eye due to Meibomian Gland Dysfunction (MGD).

Methods: This prospective study measured tear break up time (TBUT) before and after treatment with red light technology with wavelengths of light between 600nm and 650 nm. Patients were selected based on dry eye symptoms, TBUT less than 10 sec, and clinical observation of MGD. Patients were instructed to place the RLT over closed eyes for 3 minutes on each eye at least twice a week. Patients could not use the RLT more than once a day. 52 patients were included in the study and were treated for 3 months.

Results: TBUT data before and after treatment was achieved on 81 eyes. The mean TBUT before treatment was 3.62 sec with a standard deviation of 2.05. Values ranged from 0.9 sec to 8.54 sec. Mean TBUT post treatment was 5.87sec with a standard deviation of 2.95. Values ranged from 1.5 sec to 16.19 sec. T-test results show the difference to be statistically significant (P <0.001). No statistical significance found between right eyes (N=41) and left eyes (N=40) before treatment (P=0.53) or after treatment (P=0.75).  Over 90% of patients experienced improvement in their dry eye symptoms.

Conclusion:  Our prospective study showed that Red Light Therapy improved the signs and symptoms of dry eye disease.  RLT could be an new way of treating DED.

We have been working for 4 years to bring this technology to patients.  After several prototypes and studies we have found an effective way of treating Meibomian Gland Dysfunction and Dry Eye Disease.  This research used one of our latest prototypes.  We have named our device the Quantum.  Patients have begun calling it the Q.  Stay tuned for its release.  We look forward to presenting the latest in Dry Eye Research.

← Back to Blog